Correlation Between Arcus Biosciences and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Abcellera Biologics, you can compare the effects of market volatilities on Arcus Biosciences and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Abcellera Biologics.
Diversification Opportunities for Arcus Biosciences and Abcellera Biologics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Arcus and Abcellera is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Abcellera Biologics
Given the investment horizon of 90 days Arcus Biosciences is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Arcus Biosciences is 1.38 times less risky than Abcellera Biologics. The stock trades about -0.34 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 295.00 in Abcellera Biologics on October 13, 2024 and sell it today you would lose (3.00) from holding Abcellera Biologics or give up 1.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcus Biosciences vs. Abcellera Biologics
Performance |
| Timeline |
| Arcus Biosciences |
| Abcellera Biologics |
Arcus Biosciences and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and Abcellera Biologics
The main advantage of trading using opposite Arcus Biosciences and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |